GUVEN, UMMU
GUVEN, UMMU
Dipartimento di Bioscienze
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3
2022 M.D. Parenti, M. Naldi, E. Manoni, E. Fabini, D. Cederfelt, V.O. Talibov, V. Gressani, U. Guven, V. Grossi, C. Fasano, P. Sanese, K. De Marco, A.A. Shtil, A.V. Kurkin, A. Altieri, U.H. Danielson, G. Caretti, C. Simone, G. Varchi, M. Bartolini, A. Del Rio
Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality
2020 P. Sanese, C. Fasano, G. Buscemi, C. Bottino, S. Corbetta, E. Fabini, V. Silvestri, V. Valentini, V. Disciglio, G. Forte, M. Lepore Signorile, K. De Marco, S. Bertora, V. Grossi, U. Guven, N. Porta, V. Di Maio, E. Manoni, 5. Gianluigi Giannelli, M. Bartolini, A. Del Rio, G. Caretti, L. Ottini, C. Simone
Titolo | Data di pubblicazione | Autori | Tipo | File | Abstract |
---|---|---|---|---|---|
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3 | 2022 | Guven, UmmuCaretti, Giuseppina + | Article (author) | - | |
Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality | 2020 | Cinzia BottinoSilvia CorbettaUmmu GuvenGiuseppina Caretti + | Article (author) | - |